Fund Management at Engine No 1’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,736
Closed -$489K 272
2023
Q3
$489K Buy
4,736
+470
+11% +$52.4K 0.07% 245
2023
Q2
$518K Buy
4,266
+258
+6% +$34.4K 0.1% 213
2023
Q1
$616K Buy
4,008
+370
+10% +$61K 0.12% 158
2022
Q4
$653K Buy
3,638
+404
+12% +$66.1K 0.16% 132
2022
Q3
$382K Sell
3,234
-258
-7% -$39.1K 0.11% 179
2022
Q2
$499K Buy
3,492
+507
+17% +$72.5K 0.13% 158
2022
Q1
$514K Buy
+2,985
New +$503K 0.13% 155

Other funds holding MRNA

Fund Management at Engine No 1's MRNA Position: Q4 2023 in Review

Fund Management at Engine No 1 sold out of Moderna (MRNA) in Q4 2023, closing a stake of 4,736 shares — an estimated $489K sold.

Fund Management at Engine No 1 first reported a position in MRNA in Q1 2022 and held it in 7 quarters. The position peaked at $653K in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Fund Management at Engine No 1 reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Fund Management at Engine No 1 sold 4,736 Moderna shares in Q4 2023, an estimated $489K.
  • Fund Management at Engine No 1 first reported a position in Moderna in Q1 2022 and held it in 7 quarters.
  • Fund Management at Engine No 1's Moderna position peaked at $653K in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Fund Management at Engine No 1's 13F filing for Q4 2023.